JNJ241108P139000
- 0.10
- +0.08+400.00%
ジョンソン・エンド・ジョンソンのニュース一覧
Johnson & Johnson Darzalex Shows Efficacy in Early-stage Multiple Myeloma
AI Robot Trader Dumped Microsoft, Amazon Stocks and Went Defensive. Here's What It Bought. -- Barrons.com
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
With 73% Ownership of the Shares, Johnson & Johnson (NYSE:JNJ) Is Heavily Dominated by Institutional Owners
Is Johnson & Johnson (JNJ) the Best Pharma Stock to Buy Right Now?
Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare
Alvotech, Advanz's Application for AVT05 Accepted by European Medicines Agency
New Study Reveals Another Benefit in Using Novo Nordisk's Wegovy in Obesity
Stocks That Hedge Funds Moved From Long to Short in August - Jefferies
Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific
AbbVie Lifts Outlook Again on Immunology Demand; Dividend Raised
强生(JNJ.US)单抗疗法公布3期积极数据 实现显著的临床缓解和内镜应答
Grifols's Fibrin Sealant Approved by FDA for Children; Shares Rise
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
DOJ Throws Wrench Into J&J Bankruptcy Plan to Settle Talc Suits
AbbVie to Acquire Aliada Therapeutics for $1.4 Billion -- Update
J&J Impella ECP Heart Pump Meets Primary Endpoint
JNJ's Subcutaneous Tremfya Demonstrates Efficacy in Crohn's
Johnson & Johnson Says Phase 3 Trial of Crohn's Disease Treatment Showed High Remission Rates
Healthcare Stocks Await Election Result. How a Trump or Harris Presidency Could Move Markets. -- Barrons.com